ArticleDrug testing and analysis2026
Recreational Drug Use at a Music Festival: A Dual Approach Using Hair Biomarkers Analysis and Participant Self-Reported Drug Use.
Article in Drug testing and analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Broad-spectrum LC-MS/MS hair analysis for monitoring recreational drug use in electronic dance music festival attendees.Forensic toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The growing prevalence of substance use and its associated health consequences highlights the need for reliable approaches to assess consumption patterns and validate self-reported data. This study, conducted at an international music festival in Portugal, aimed to characterise substance use by integrating objective toxicological findings with self-reported information. Quantitative hair analysis was combined with survey data from 249 participants recruited in 2022 and 2023. Hair samples were analysed by liquid chromatography-tandem mass spectrometry to detect psychoactive substances and metabolites. Self-reported use was assessed across multiple timeframes, from same-day consumption to use within the previous year. Alcohol (96%) and cannabinoids (90%) were the most frequently self-reported substances overall, based on lifetime self-reported use. Overall, 50% of participants tested positive for at least one compound in the analysed hair samples, with cocaine, MDMA and ketamine being the most commonly detected substances (24.5%, 24.1% and 22.9%, respectively). Some participants who denied consumption tested positive, particularly for MDMA and ketamine. Self-reported non-use was inversely associated with hair positivity for MDMA (OR = 0.25, 95% CI: 0.09-0.65) and ketamine (OR = 0.19, 95% CI: 0.09-0.40), compared with self-reported users. Discrepancies were also observed for cannabinoids, highlighting limitations of self-reported data. Strong correlations were identified between cocaine and benzoylecgonine, and between cannabis-related analytes (cannabidiol and THC), supporting the consistency of the toxicological results. Integrating self-reported data with objective biological measures improved data reliability, revealed polydrug use patterns and supported substance use monitoring in high-risk populations such as music festival attendees in this high-exposure festival setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.